Directory
>
Mike Sherman
Mike Sherman
Member Board of Directors | Chimerix, Inc.
Carmel, Indiana, United States
Mike Sherman
Summary
Mike Sherman is a seasoned life science executive with extensive experience in biotechnology and pharmaceutical industries. Currently serving as a Board Director at Werewolf Therapeutics and Chairman of the Board at Chimerix, he has a proven track record of successfully repositioning companies and leading them to significant milestones, including FDA approvals and strategic acquisitions. His leadership at Chimerix resulted in the sale of TEMBEXA, enhancing public health safety. Mike's strategic vision in oncology drug development is exemplified by the promising ONC201 trial, which targets brain cancer in children and young adults. He previously played pivotal roles at Endocyte, where he guided the company towards radioligand therapy and led its acquisition by Novartis. With a BA in Economics from DePauw University and an MBA from Dartmouth's Tuck School, Mike combines strong academic credentials with practical expertise in finance and strategic planning. His commitment extends beyond corporate roles to community service as a past Chairman of the Board for the Children's Museum of Indianapolis.
Mike Sherman
Work Experience
Member Board of Directors at
TOLREMO therapeutics
March 2024 - Present
Board Chair at
Chimerix, Inc.
August 2023 - Present
Member Board Of Directors at
Werewolf Therapeutics
May 2021 - Present
President and CEO, Chimerix at
Chimerix, Inc.
April 2019 - August 2023
Board Of Trustees and Past Chair at
The Children's Museum of Indianapolis
January 2012 - December 2022
Member Board Of Directors at
Biospecifics Technologies
April 2020 - December 2020
President and CEO at
Endocyte
June 2016 - January 2019
Member Board Of Directors at
Mead Johnson Nutrition
February 2015 - June 2017
Chief Operating Officer & Chief Financial Officer at
Endocyte
June 2014 - June 2016
CFO at
Endocyte
January 2007 - June 2014
VP Finance and Strategic Planning at
Boston Scientific
January 2005 - January 2006
VP Finance & IT Europe at
Boston Scientific
January 2002 - January 2005
Controller, Chief Accounting Officer at
Boston Scientific
January 2000 - January 2002
Various financial and business development roles at
Boston Scientific
January 1992 - January 2000
Various financial and business development roles at
Eli Lilly and Company
January 1988 - January 1992
Mike Sherman
Education
Dartmouth College - The Tuck School of Business at Dartmouth, Master Of Business Administration (M.B.A.)
January 1990 - January 1992
January 1984 - January 1988
Broad Ripple
Broad Ripple
Frequently Asked Questions about Mike Sherman
What is Mike Sherman email address?
Mike Sherman's primary email address is ********@chimerix.com. To view the full verified email and additional contact details, sign up for free with Muraena.
What company does Mike Sherman work for?
Mike Sherman is a Member Board of Directors at Chimerix, Inc., a company specializing in Commercial physical research.
Where Mike Sherman graduated from?
Mike Sherman holds a degree in from Dartmouth College - The Tuck School of Business at Dartmouth.
How can I directly contact Mike Sherman?
To contact Mike Sherman directly, you can use the email address ********@chimerix.com. Complete contact information is available upon registration with Muraena.
Who is Mike Sherman?
Mike Sherman is a seasoned life science executive with extensive experience in biotechnology and pharmaceutical industries. Currently serving as a Board Director at Werewolf Therapeutics and Chairman of the Board at Chimerix, he has a proven track record of successfully repositioning companies and leading them to significant milestones, including FDA approvals and strategic acquisitions. His leadership at Chimerix resulted in the sale of TEMBEXA, enhancing public health safety. Mike's strategic vision in oncology drug development is exemplified by the promising ONC201 trial, which targets brain cancer in children and young adults. He previously played pivotal roles at Endocyte, where he guided the company towards radioligand therapy and led its acquisition by Novartis. With a BA in Economics from DePauw University and an MBA from Dartmouth's Tuck School, Mike combines strong academic credentials with practical expertise in finance and strategic planning. His commitment extends beyond corporate roles to community service as a past Chairman of the Board for the Children's Museum of Indianapolis.
Mike`s contact details
********@chimerix.com
********@endocyte.com
************@bsci.com
********@werewolftx.com
Colleagues
Executive Director of Quality Assurance
Vice President, Biostatistics
Chief Scientific Officer
Executive Director, Human Resources
Vice President Regulatory Affairs
Executive Director, Nonclinical Development Strategy and Translational Medicine
VP Clinical Pharmacology/Translational Medicine
Retired